Laboratories Work with Logistics Partners to Maintain Business Continuity During COVID-19 Crisis
Companies in the central lab market have been under scrutiny for minimizing potential disruptions to logistical movements of human samples and potential supply issues for clinical kits during the ongoing COVID-19 pandemic. LabConnect - a preeminent provider of central laboratory support services is increasing efforts to closely work with its logistics providers and courier partners to implement alternative transportation solutions, owing to increased cost of transporting supplies.
Stakeholders in the central lab market are collaborating with network laboratories to assess the current coronavirus situation and plan its potential impact on lab testing services. Laboratory vendors are closely monitoring and updating their business continuity plans in severely affected COVID-19 regions. Stakeholders are working closely with their staff to monitor subject compliance.
Request a sample to get extensive insights into the Central Lab Market
Additional Training of Non-physician Medical Specialists Accelerates Lab Procedure Outcomes
The central lab market is estimated to surpass US$ 4.1 Bn mark by 2030. However, central lab stakeholders are posed with many challenges, such as time consuming processes, since several sites samples need to reach one lab and may take several days. Hence, central labs are now sharing this responsibility with local lab facilities whilst increasing R&D to adopt processes that accelerate their lab procedures.
On the other hand, the German healthcare system in the central lab market poses issue in invoicing medical services to non-physician medical specialists in hospitals due to the scarcity of medical professionals. Hence, the German Society for Laboratory Medicine (DGKL) is increasing efforts to provide additional training in a master program in laboratory medicine aimed at medical professionals to facilitate invoicing for lab services in hospitals.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Encrypted Connections Help Secure Real-time Laboratory Information Data Portals
The central lab market is slated to register a favorable CAGR of ~6% during the forecast period. Companies such as the Eurofins Central Laboratory is making the use of its real-time laboratory information data portal called Fetch for investigator sites and sponsors to have access to the data for their user accounts. Lab professionals are increasing efforts to provide 24/7 secured access to clinical trial information and authorized data reports. Companies are collaborating with software developers to secure laboratory information data portals with encrypted connections.
Companies Deploy AI, Automation, Blockchain Technologies to Support Central Labs
A plethora of technological and software innovations are storming the central lab market. Q2 Solutions-a global clinical trial laboratory services organization is supporting central labs with innovations such as artificial intelligence (AI) protocol reading, sample & consent tracking, and next-gen flow cytometry result reporting automation, among others.
Direct to patient kit shipments, blockchain for sample tracking, and electronic histology & pathology reports are benefitting stakeholders in the central lab market. They are unlocking growth opportunities in supporting decentralized virtual trials innovation. Thus, companies are partnering with mobile nurse and phlebotomy companies to enable in-home specimen collection from individuals and patients alike.
Compliance with CAP, CLIA Standards Boosts Credibility of Stakeholders
Efficient service and quality data without compromise has become important for companies in the central lab market. PPD Laboratories’ Central Lab is gaining recognition in Asia, Europe, and North America for its global laboratory assay standardization survey i.e. GLASS, which is harmonizing processes across locations. Companies are increasing efforts to streamline auditing, deviation management, and standard operating procedures.
Companies in the central lab market are committing to operational excellence in order to comply with the global standards as suggested by the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the likes. As such, real-time central lab database management platforms are becoming a recurring market trend, as it can be automatically integrated with the patient or medical data of a clinical trial management system.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Central Lab Market
Analysts’ Viewpoint
Companies in the central lab market are increasing efforts to implement home visit testing for several COVID-19 research studies and provide high quality support to logistics courier partners. Investigator site portals are providing intuitive and interactive tools for central lab sites in order to manage register samples, subject enrollment, order collection kits, etc. Electronic lab requisition reduces the risk of sample loss by enabling a chain of custody before the sample leaves the clinic. However, study teams face complexities such as working with niche laboratories to evaluate decentralized clinical trial designs. In order to overcome these challenges, companies should transition toward AI, blockchain, and automation technologies in laboratory trials management systems and for sample tracking.
Central Lab Market: Overview
- Central labs are designed to provide services to support clinical trials for upcoming drugs, genetic testing services for various genetic diseases such as Parkinson’s, Alzheimer’s, sickle cell anemia, and microbiology testing services such as testing the kinetics and growth of different microbes
- These labs are also used to test the morphology, anatomy, physiology, and activity toward response of various therapeutic agents that prevent the development and replication of microbes
- The global lab market has experienced significant growth over the past decade due to rise in the number of trials in different areas such as pathological trials, clinical trials, microbiological trials, genetic testing trials, and microbiological trials
- Central labs are used by pharmaceutical companies for pharmacology and pharmacovigilance; biotechnology companies for testing, detecting, development, and production of new products, and academic & research institutes for research purposes
Central Lab Market: Drivers
- Surge in the number of patients suffering and affected by different diseases such as cancer and circulatory diseases, increase in the number of clinical trials for the development of various drugs, rise in the number of cases & prevalent occurrence, and advancement in technology, new therapies, and drugs propel the growth of the global central lab market. Increase in the number of patients across the globe is a major factor boosting the growth of the global central lab market.
- Rise in outsourcing by pharmaceutical and biotechnological companies is projected to drive the global central lab market during the forecast period
Market Segmentation: Central Lab Market
- In terms of product, the global central lab market has been classified into genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services, clinical research & trial services, and others. The biomarker services segment is projected to capture the largest share of the global central lab market during the forecast period.
- Based on end user, the global central lab market has been categorized into pharmaceutical companies, biotechnology companies, and academic & research institutes. The pharmaceutical companies segment dominated the global central lab market in terms of revenue in 2019.
- Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.
Regional Overview: Central Lab Market
- In terms of region, the global central lab market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
- The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
- The study also offers a list of recommendations, highlights, and useful insights of the global central lab market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process
Major Players
- The central lab market report concludes with the company profiles section, which includes key information about major players in the global central lab market
- Leading players analyzed in the central lab market report include
- ACM Global Central Lab
- Barc Lab (Cerba Research)
- Bioscientia (Sonic Healthcare)
- Celerion
- CIRION BioPharma Research
- Clinical Reference Laboratory
- Lab Corp/Covance
- Eurofins Central Laboratory
- Frontage Laboratories, Inc.
- ICON Central Labs
- INTERLAB Central Lab Services
- InVitro International
- LabConnect
- Each of these players has been profiled in the market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
Central Lab Market – Scope of the Report
TMR’s report on the global central lab market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global central lab market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global central lab market from 2020 to 2030.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the central lab market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the central lab market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global central lab market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global central lab market.
The report delves into the competition landscape of the global central lab market. Key players operating in the global central lab market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global central lab market profiled in this report.
Key Questions Answered in Central Lab Market Report
- What is the sales/revenue generated by central lab market across all regions during the forecast period?
- What are the opportunities in the global central lab market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which product is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Central Lab Market – Research Objectives and Research Approach
The comprehensive report on the global central lab market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global central lab market in terms of service type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global central lab market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Central Lab Market – Segmentation
TMR’s study on the global central lab market includes information divided into three segments: product, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global central lab market are discussed in detail.
|
Product |
|
| End User |
|
| Region |
|
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Central Lab Market Forecast
4.4. Global Central Lab Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Strategies Adopted by Top 3 Players
6. Global Central Lab Market Analysis, by Product
6.1. Introduction
6.2. Global Central Lab Market Value Share Analysis, by Product
6.3. Global Central Lab Market Forecast, by Product
6.3.1. Genetic Services
6.3.2. Biomarker Services
6.3.3. Microbiology Services
6.3.4. Anatomic Pathology/Histology
6.3.5. Specimen Management & Storage
6.3.6. Special Chemistry Services
6.3.7. Clinical Research & Trial Services
6.3.8. Others
6.4. Global Central Lab Market Analysis, by Product
6.5. Global Central Lab Market Attractiveness Analysis, by Product
7. Global Central Lab Market Analysis, by End-user
7.1. Introduction
7.2. Global Central Lab Market Value Share Analysis, by End-user
7.3. Global Central Lab Market Forecast, by End-user
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Academic & Research Institutes
7.4. Global Central Lab Market Analysis, by End-user
7.5. Global Central Lab Market Attractiveness Analysis, by End-user
8. Global Central Lab Market Analysis, by Region
8.1. Global Central Lab Market Forecast, by Region
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Latin America
8.1.5. Middle East & Africa
9. North America Central Lab Market Analysis
9.1. North America Central Lab Market Overview
9.2. North America Central Lab Market Value Share and Attractiveness Analysis, by Country
9.3. North America Central Lab Market Forecast, by Country
9.3.1. U.S.
9.3.2. Canada
9.4. North America Central Lab Market Value Share and Attractiveness Analysis, by Product
9.5. North America Central Lab Market Forecast, by Product
9.5.1. Genetic Services
9.5.2. Biomarker Services
9.5.3. Microbiology Services
9.5.4. Anatomic Pathology/Histology
9.5.5. Specimen Management & Storage
9.5.6. Special Chemistry Services
9.5.7. Clinical Research & Trial Services
9.5.8. Others
9.6. North America Central Lab Market Value Share and Attractiveness Analysis, by End-user
9.7. North America Central Lab Market Forecast, by End-user
9.7.1. Pharmaceutical Companies
9.7.2. Biotechnology Companies
9.7.3. Academic & Research Institutes
10. Europe Central Lab Market Analysis
10.1. Europe Central Lab Market Overview
10.2. Europe Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.3. Europe Central Lab Market Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Europe Central Lab Market Value Share and Attractiveness Analysis, by Product
10.5. Europe Central Lab Market Forecast, by Product
10.5.1. Genetic Services
10.5.2. Biomarker Services
10.5.3. Microbiology Services
10.5.4. Anatomic Pathology/Histology
10.5.5. Specimen Management & Storage
10.5.6. Special Chemistry Services
10.5.7. Clinical Research & Trial Services
10.5.8. Others
10.6. Europe Central Lab Market Value Share and Attractiveness Analysis, by End-user
10.7. Europe Central Lab Market Forecast, by End-user
10.7.1. Pharmaceutical Companies
10.7.2. Biotechnology Companies
10.7.3. Academic & Research Institutes
11. Asia Pacific Central Lab Market Analysis
11.1. Asia Pacific Central Lab Market Overview
11.2. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Asia Pacific Central Lab Market Forecast, by Country/Sub-region
11.3.1. Japan
11.3.2. China
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by Product
11.5. Asia Pacific Central Lab Market Forecast, by Product
11.5.1. Genetic Services
11.5.2. Biomarker Services
11.5.3. Microbiology Services
11.5.4. Anatomic Pathology/Histology
11.5.5. Specimen Management & Storage
11.5.6. Special Chemistry Services
11.5.7. Clinical Research & Trial Services
11.5.8. Others
11.6. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by End-user
11.7. Asia Pacific Central Lab Market Forecast, by End-user
11.7.1. Pharmaceutical Companies
11.7.2. Biotechnology Companies
11.7.3. Academic & Research Institutes
12. Latin America Central Lab Market Analysis
12.1. Latin America Central Lab Market Overview
12.2. Latin America Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Latin America Central Lab Market Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Central Lab Market Value Share and Attractiveness Analysis, by Product
12.5. Latin America Central Lab Market Forecast, by Product
12.5.1. Genetic Services
12.5.2. Biomarker Services
12.5.3. Microbiology Services
12.5.4. Anatomic Pathology/Histology
12.5.5. Specimen Management & Storage
12.5.6. Special Chemistry Services
12.5.7. Clinical Research & Trial Services
12.5.8. Others
12.6. Latin America Central Lab Market Value Share and Attractiveness Analysis, by End-user
12.7. Latin America Central Lab Market Forecast, by End-user
12.7.1. Pharmaceutical Companies
12.7.2. Biotechnology Companies
12.7.3. Academic & Research Institutes
13. Middle East & Africa Central Lab Market Analysis
13.1. Middle East & Africa Central Lab Market Overview
13.2. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Middle East & Africa Central Lab Market Forecast, by Country/Sub-region
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by Product
13.5. Middle East & Africa Central Lab Market Forecast, by Product
13.5.1. Genetic Services
13.5.2. Biomarker Services
13.5.3. Microbiology Services
13.5.4. Anatomic Pathology/Histology
13.5.5. Specimen Management & Storage
13.5.6. Special Chemistry Services
13.5.7. Clinical Research & Trial Services
13.5.8. Others
13.6. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by End-user
13.7. Middle East & Africa Central Lab Market Forecast, by End-user
13.7.1. Pharmaceutical Companies
13.7.2. Biotechnology Companies
13.7.3. Academic & Research Institutes
14. Competition Landscape
14.1. Competition Matrix
14.2. Company Share Analysis, 2019
14.3. Company Profiles
14.3.1. ACM Global Central Lab
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Barc Lab (Cerba Research)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Bioscientia (Sonic Healthcare)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Celerion
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. CIRION BioPharma Research
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Clinical Reference Laboratory
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Lab Corp/Covance
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Eurofins Central Laboratory
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Frontage Laboratories, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. ICON Central Labs.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. INTERLAB Central Lab Services.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. InVitro International
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. LabConnect
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Medpace
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Overview
14.3.14.3. Product Portfolio
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. MLM Medical Labs GmbH.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
14.3.16. PPD
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Product Portfolio
14.3.16.3. SWOT Analysis
14.3.16.4. Strategic Overview
14.3.17. Q² Solutions
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Product Portfolio
14.3.17.3. SWOT Analysis
14.3.17.4. Strategic Overview
14.3.18. Synevo Central Lab
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Product Portfolio
14.3.18.3. SWOT Analysis
14.3.18.4. Strategic Overview
List of Tables
Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Central Lab Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Central Lab Market Value Share, by Product (2019)
Figure 03: Global Central Lab Market Value Share, by End-user (2019)
Figure 04: Global Central Lab Market Value Share, by Region (2019)
Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 06: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2018–2030
Figure 07: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2018–2030
Figure 08: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2018–2030
Figure 09: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2018–2030
Figure 10: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2018–2030
Figure 11: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2018–2030
Figure 12: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2018–2030
Figure 13: Global Central Lab Market Revenue (US$ Mn), by Others, 2018–2030
Figure 14: Global Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 15: Global Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 16: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2018–2030
Figure 17: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2018–2030
Figure 18: Global Central Lab Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030
Figure 19: Global Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2019 and 2030
Figure 21: Global Central Lab Market Analysis, by Region
Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 23: North America Central Lab Market Value Share (%), by Country, 2019 and 2030
Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2020–2030
Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 27: North America Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 28: North America Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 30: Europe Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 31: Europe Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030
Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 34: Europe Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 35: Europe Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 36: Asia Pacific Central Lab Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 37: Asia Pacific Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030
Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 41: Asia Pacific Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 42: Asia Pacific Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 44: Latin America Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030
Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 48: Latin America Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 49: Latin America Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 51: Middle East & Africa Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030
Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2019 and 2030
Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2020–2030
Figure 55: Middle East & Africa Central Lab Market Value Share Analysis, by End-user, 2019 and 2030
Figure 56: Middle East & Africa Central Lab Market Attractiveness Analysis, by End-user, 2020–2030
Figure 57: ACM Global Laboratories Business Overview, Strategic Overview, SWOT Analysis
Figure 58: Barc Lab’s Business Overview, Strategic Overview, and SWOT Analysis
Figure 59: Bioscientia (Sonic Healthcare) Business Overview
Figure 60: Bioscientia (Sonic Healthcare) Financial Status (revenue, net sales and net profit)
Figure 61: Bioscientia (Sonic Healthcare) Strategic Overview, SWOT Analysis
Figure 62: Celerion’s Business Overview, Strategic Overview, and SWOT Analysis
Figure 63: CIRION BioPharma Research’s Business Overview, Strategic Overview and SWOT Analysis
Figure 64: Clinical Reference Laboratory’s Business Overview, Strategic Overview, and SWOT Analysis
Figure 65: Lab Corp/Covance’s Business Overview
Figure 66: Lab Corp/Covance’s Financial Status (revenue, net sales and net profit)
Figure 67: Lab Corp/Covance’s Strategic Overview, SWOT Analysis
Figure 68: Eurofins Central Laboratory’s Business Overview
Figure 69: Eurofins Central Laboratory Financial Status (revenue, Y-o-Y growth (%), net sales and profit)
Figure 70: Eurofins Central Laboratory’s Strategic Overview, SWOT Analysis
Figure 71: Frontage Laboratories’ Business Overview
Figure 72: Frontage Laboratories Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)
Figure 73: Frontage Laboratories’ Strategic Overview, SWOT Analysis
Figure 74: ICON Central Labs Business Overview
Figure 75: ICON Central Labs Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)
Figure 76: ICON Central Labs Strategic Overview, SWOT Analysis
Figure 77: InterLab Research Laboratory’s Business Overview, Strategic Overview and SWOT Analysis
Figure 78: InVitro International’s Business Overview
Figure 79: InVitro International’s Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)
Figure 80: InVitro International’s Strategic Overview, SWOT Analysis
Figure 81: LabConnect Business Overview, Strategic Overview, SWOT Analysis
Figure 82: Medpace’s Business Overview
Figure 83: Medpace’s Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)
Figure 84: Medpace’s Strategic Overview, SWOT Analysis.
